Business Description
CSPC Pharmaceutical Group Limited is a China-based company that develops, manufactures, and sells a wide range of medicines and health products, serving customers across Asia, Europe, North America, and beyond. Its portfolio covers treatments for conditions such as stroke, cancer, diabetes, hypertension, infections, and pain, alongside vitamins, antibiotics, and functional food products. The company also works with AstraZeneca to research new treatments for obesity and type 2 diabetes. Founded in 1992 and headquartered in Shijiazhuang, China, it was previously called China Pharmaceutical Group Limited before taking its current name in 2013.
